Category
List all categories in the database.
GET /categories/?format=api&page=2
http://api.gregory-ms.com/categories/?format=api&page=3", "previous": "http://api.gregory-ms.com/categories/?format=api", "results": [ { "category_id": 15, "category_description": "Bu Shen Yi Sui capsule (BSYSC) is a traditional Chinese herbal medicine.", "category_name": "Bu Shen Yi Sui Capsules", "category_slug": "bu-shen-yi-sui-capsules", "category_terms": [ "BSYS", "bsysc", "bu shen yi sui", "bu shen yi sui capsule", "Bu Shen Yi Sui" ], "article_count": 5 }, { "category_id": 16, "category_description": "https://neurosciencenews.com/inflammation-lipid-ms-20501/", "category_name": "Maresin-1", "category_slug": "maresin-1", "category_terms": [ "Maresin-1", "MaR1", "maresin-1", "mar1" ], "article_count": 2 }, { "category_id": 17, "category_description": "All articles matching nuclear medicine, molecular imaging, or $theranostic", "category_name": "Nuclear Medicine", "category_slug": "nuclear-medicine", "category_terms": [ "nuclear medicine", "molecular imaging", "theranostic" ], "article_count": 9 }, { "category_id": 18, "category_description": "Search terms: telerehabilitation, physical therapy, virtual reality, gamification, neurostimulation, cognitive training, spasticity, motor control.\n\nSuggested by Alejandro Carrabs", "category_name": "Physical therapy and Telerehabilitation", "category_slug": "physical-therapy-and-telerehabilitation", "category_terms": [ "telerehabilitation", "physical therapy", "virtual reality", "gamification", "neurostimulation", "cognitive training", "spasticity", "motor control" ], "article_count": 177 }, { "category_id": 20, "category_description": "IMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin sheath protecting the nerves. ImotopesTM stimulate the expansion of a population of antigen-specific cytolytic CD4 T cells that reset the body’s autoimmune response. By specifically interrupting the autoantigen-driven disease pathway, Imotopes™ halt the attack on the central nervous system. IMCY-0141 has shown promising results in several MS preclinical models, demonstrating an immune response that supports the proposed mode of action. Notably, in those models, Imotopes™ also demonstrated induction of a memory response so that the treatment effect is long-lasting and require less frequent dosing regimens.", "category_name": "IMCY-0141", "category_slug": "imcy-0141", "category_terms": [ "IMCY-0141" ], "article_count": 0 }, { "category_id": 21, "category_description": "sg", "category_name": "CNM-Au8", "category_slug": "cnm-Au8", "category_terms": [ "CNM-Au8" ], "article_count": 1 }, { "category_id": 22, "category_description": "sg", "category_name": "Hizentra", "category_slug": "hizentra", "category_terms": [ "hizentra" ], "article_count": 0 }, { "category_id": 23, "category_description": "sg", "category_name": "Neurovax", "category_slug": "neurovax", "category_terms": [ "neurovax" ], "article_count": 0 }, { "category_id": 24, "category_description": "sg", "category_name": "IMU-838", "category_slug": "imu-838", "category_terms": [ "IMU-838" ], "article_count": 0 }, { "category_id": 26, "category_description": "sg", "category_name": "ICP-022", "category_slug": "icp-022", "category_terms": [ "ICP-022" ], "article_count": 0 } ] }{ "count": 47, "next": "